510(k) · Cleared
ClearedCystatin C Immunoparticles, Control Set, Calibrator
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Dako A/S · NDY Test, Cystatin C
Cleared on Sep 3, 2004 as substantially equivalent to K003503 (Dade Behring, Inc., 2001) and 2 other predicates after a 79-day review. Its family tree reaches back 1 generation to 1995. 8 later devices descend from it.
- Decided
- Sep 3, 2004
- Review
- 79 days
- Class
- Class II
- Product code
- NDY
- Recalls
- None
- Predicates
- 3
Its longest line of descent runs back 1 generation to K953239 (1995). 3 ancestors in all. 8 later devices descend from it, 3 citing it directly.
- Root · 1 generation backK953239 Boehringer Mannheim/Hitachi 917 AnalyzerBoehringer Mannheim Corp. · 1995 · Recalled
- This deviceK041627 Cystatin C Immunoparticles, Control Set, CalibratorDako A/S · 2004
- Descendant · cites it directly · 5 of its ownK080811 Tina-Quant Cystatin C, Calibrator F.a.S. Cystatin C and Cystatin C…Roche Diagnostics Corp. · 2008
- Descendant · 2 generations on · 4 of its ownK141143 Cobas C Tina-Quant Cystatin C Gen.2 Assay, C.F.a.S. Cystatin C…Roche Diagnostics · 2014
- Descendant · 3 generations on · 1 of its ownK171072 N Latex Cystatin C; N Protein Standard UYSiemens Healthcare Diagnostics Products GmbH · 2017
- Descendant · 3 generations on · 1 of its ownK161817 Tina-quant Cystatin C Gen.2Roche Diagnostics Operations (Rdo) · 2016
- Descendant · 4 generations on · 0 of its ownK242585 Cystatin CSENTINEL CH. SpA · 2025
Showing 5 of 8 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 8 · See all- K080811Tina-Quant Cystatin C, Calibrator F.a.S. Cystatin C and Cystatin C Andcystatin C Control…Roche Diagnostics Corp. · 2008 · cites it directly5descendants
- K141143Cobas C Tina-Quant Cystatin C Gen.2 Assay, C.F.a.S. Cystatin C Calibrator, Cystatin C…Roche Diagnostics · 2014 · 2 generations on4descendants
- K171072N Latex Cystatin C; N Protein Standard UYSiemens Healthcare Diagnostics Products GmbH · 2017 · 3 generations on1descendant
- K161817Tina-quant Cystatin C Gen.2Roche Diagnostics Operations (Rdo) · 2016 · 3 generations on1descendant
- K242585Cystatin CSENTINEL CH. SpA · 2025 · 4 generations on0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K953239 | Boehringer Mannheim/Hitachi 917 Analyzer | Boehringer Mannheim Corp. | 1995 | 18 |
| 0 (this device) | K041627 | Cystatin C Immunoparticles, Control Set, Calibrator | Dako A/S | 2004 | — |
| +1 | K080811 | Tina-Quant Cystatin C, Calibrator F.a.S. Cystatin C and Cystatin C Andcystatin… | Roche Diagnostics Corp. | 2008 | — |
| +2 | K141143 | Cobas C Tina-Quant Cystatin C Gen.2 Assay, C.F.a.S. Cystatin C Calibrator… | Roche Diagnostics | 2014 | — |
| +3 | K171072 | N Latex Cystatin C; N Protein Standard UY | Siemens Healthcare Diagnostics Products GmbH | 2017 | — |
| +3 | K161817 | Tina-quant Cystatin C Gen.2 | Roche Diagnostics Operations (Rdo) | 2016 | — |
| +4 | K242585 | Cystatin C | SENTINEL CH. SpA | 2025 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2001 | 2 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2007 | 1 | 0 |
| 2008 | 1 | 0 |
| 2012 | 1 | 0 |
| 2014 | 1 | 0 |
| 2016 | 1 | 0 |
| 2017 | 1 | 0 |
| 2018 | 1 | 0 |
| 2025 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in NDY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new NDY device
- #1 K242585 Cystatin Cscore 10.5 · 5 generations · no Class I recall
What was it cleared against? (3)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K003503 | N Latex Cystatin CSummary page 1…ator, Secondary (21 CFR 862.1150) Predicate Devices For Cystatin C Immunoparticles: N Latex Cystatin C Test Kit, Dade Behring, Inc. (K003503) Creatinine Plus, Roche Diagnostics Corp. (K953239) For Cystatin C Control Set: N… | 2001 |
| * | K953239 | Boehringer Mannheim/Hitachi 917 AnalyzerSummary page 1…For Cystatin C Immunoparticles: N Latex Cystatin C Test Kit, Dade Behring, Inc. (K003503) Creatinine Plus, Roche Diagnostics Corp. (K953239) For Cystatin C Control Set: N Cystatin C Control, Dade Behring, Inc. (K003503)… | 1995 |
| * | K003501 | N Protein Standard UY CalibratorSummary page 1…N Cystatin C Control, Dade Behring, Inc. (K003503) For Cystatin C Calibrator: N Protein Standard UY, Dade Behring, Inc. (K003501) Cystatin C Immunoparticles - Cystatin C Control Set - Cystatin C Calibrator DakoCytomation Denmark A/S… | 2001 |
What descends from it? (8)
3 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All NDY devicesNDY Test, Cystatin C: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · NDY
1in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · NDY
265in 2010
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · NDY
1in 2020
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · NDY
10in 2025
MAUDE reports naming product code NDY, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 3 | 95 | 0 | 0 |
| 2008 | 6 | 101 | 0 | 0 |
| 2009 | 1 | — | 0 | 0 |
| 2010 | 3 | 265 | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 1 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 1 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 1 |
| 2016 | 1 | — | 0 | 1 |
| 2017 | 1 | — | 0 | 2 |
| 2018 | 1 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 1 |
| 2020 | 0 | — | 1 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 2 |
| 2024 | 0 | — | 0 | 3 |
| 2025 | 1 | — | 0 | 10 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
For In Vitro Diagnostic Use. For Professional Use Only. Cystatin C Immunoparticles are intended for the quantitative determination of cystatin C in human serum, heparinized plasma and EDTA plasma by turbidimetry and nephelometry. Cystatin C measurements are used as an aid in the diagnosis and treatment of renal diseases. For In Vitro Diagnostic Use. For Professional Use Only. Cystatin C Control Set is an assayed bi-level control intended to monitor and…
Read the full statement (120 words)
For In Vitro Diagnostic Use. For Professional Use Only.
Cystatin C Immunoparticles are intended for the quantitative determination of cystatin C in human serum, heparinized plasma and EDTA plasma by turbidimetry and nephelometry. Cystatin C measurements are used as an aid in the diagnosis and treatment of renal diseases.
For In Vitro Diagnostic Use. For Professional Use Only.
Cystatin C Control Set is an assayed bi-level control intended to monitor and evaluate the precision and accuracy of the quantitative immunological determination of human cystatin C by turbidimetry or nephelometry.
For In Vitro Diagnostic Use. For Professional Use Only.
Cystatin C Calibrator is intended for establishing calibration curves for the quantitative immunological determination of human cystatin C by turbidimetry or nephelometry.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K041627 · printed Nov 6, 2026
Cite this page
510(k) Report. “K041627: Cystatin C Immunoparticles, Control Set, Calibrator.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K041627
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026